Detalimogene voraplasmid gains FDA RMAT designation, showcasing a 71% response rate in treating high-risk, BCG-unresponsive ...

When it comes to cancer care, precision isn rsquo;t a luxury mdash;it rsquo;s an essential aspect of the treatment .

WHEN Tamsyn Gerrits woke up one morning with a swollen belly, she assumed it was just bloating. But what started as mild ...